Home  /  Resource Library  /  Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study

Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study

Observational study compared CAR T Axicabtagene ciloleucel for treatment of DLBCL vs primary mediastinal b-cell lymphoma.